Howton David T 4
4 · Solid Biosciences Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences (SLDB) COO David T. Howton Sells Shares
What Happened
David T. Howton, Chief Operating Officer of Solid Biosciences (SLDB), had 14,687 restricted stock units (RSUs) convert into common shares on Feb 13, 2026. Following the vesting/conversion, he sold 7,469 shares in the open market on Feb 18, 2026 for a weighted-average price of $5.82, generating roughly $43,494. The sale was executed to cover withholding taxes related to the RSU vesting (a sell-to-cover), not a discretionary trade.
Key Details
- Transaction dates: Feb 13, 2026 (RSU conversion into shares); Feb 18, 2026 (open-market sale).
- Sale details: 7,469 shares sold at a weighted-average price of $5.82 (prices in the trades ranged $5.23–$6.14), proceeds ≈ $43,494.
- Vesting: 14,687 RSUs converted to shares on Feb 13, 2026. Per the filing, the RSUs were originally granted Feb 13, 2024 and vest 25% each year over four years.
- Tax withholding / sell-to-cover: The sale was made pursuant to a pre-existing durable automatic sales instruction (sell-to-cover) adopted Aug 16, 2024 and was not a discretionary insider sale. (Footnotes F1–F3, F4)
- Net impact from this event: Of the 14,687 shares that converted, 7,469 were sold; the remaining 7,218 shares from this vesting event were retained (based on the numbers reported).
- Filing: Report filed Feb 18, 2026 (covers the Feb 13 conversion and Feb 18 sale). No late-filing flag is indicated in the summary information provided.
Context
This was a routine sell-to-cover following RSU vesting—common for insiders to satisfy tax withholding obligations. The conversion of RSUs into shares is a non-cash derivative settlement; only the sell-to-cover sale generated cash proceeds. Such tax-driven sales are generally not viewed as an independent bullish or bearish signal about company prospects.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-13+14,687→ 112,546 total - Sale
Common Stock
[F2][F3]2026-02-18$5.82/sh−7,469$43,494→ 105,077 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-02-13−14,687→ 29,376 total→ Common Stock (14,687 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
- [F4]The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.